|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| Revenues | ||
| Commercial and Development Revenue | ||
| License and Collaboration Revenue | ||
| Total revenues | ||
| Operating costs and expenses | ||
| Cost of sales | ||
| Research and development | ||
| General and administrative | ||
| Total operating expenses | ||
| Total operating costs and expenses | ||
| Loss from operations | ||
| Other income (expense), net: | ||
| Interest income, net | ||
| Other (expense) income, net | ||
| Total other income, net | ||
| Net loss and comprehensive loss | ||
| Deemed dividend on redeemable convertible preferred stock issuances | ||
| Cumulative redeemable convertible preferred stock dividends | ||
| Net loss attributable to common stockholders | ||
| Net loss per share , basic | ||
| Net loss per share , diluted | ||
| Weighted average shares of common stock outstanding, basic | ||
| Weighted average shares of common stock outstanding, diluted |
Loading...
